An audit and feedback-based intervention to improve diabetes management in the year after transfer to adult type 1 diabetes care: A multi-center quasi-experimental study

IF 3.2 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Rayzel Shulman, Ian Zenlea, Noah Ivers, Peter C. Austin, Ping Li, Cheril Clarson, Alanna Landry, Jennifer Harrington, Geetha Mukerji, Mark R. Palmert, Janet Parsons, Zubin Punthakee, Baiju R. Shah
{"title":"An audit and feedback-based intervention to improve diabetes management in the year after transfer to adult type 1 diabetes care: A multi-center quasi-experimental study","authors":"Rayzel Shulman,&nbsp;Ian Zenlea,&nbsp;Noah Ivers,&nbsp;Peter C. Austin,&nbsp;Ping Li,&nbsp;Cheril Clarson,&nbsp;Alanna Landry,&nbsp;Jennifer Harrington,&nbsp;Geetha Mukerji,&nbsp;Mark R. Palmert,&nbsp;Janet Parsons,&nbsp;Zubin Punthakee,&nbsp;Baiju R. Shah","doi":"10.1111/dme.15444","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>To test whether an audit and feedback-based intervention improved HbA1c 12 months after transfer to type 1 diabetes adult care.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Multi-centre, quasi-experimental pre-post study of an AF-based intervention targeting paediatric diabetes teams, which encouraged the implementation of an evidence-informed structured transition process at five paediatric diabetes centres in Ontario, Canada. Participants entered the study at their final paediatric visit. A parallel control cohort was ascertained using population-based administrative datasets. The primary outcome was HbA1c 12 months after transfer. The main exposure was the study period: pre-implementation (June 2018–May 2019); early-implementation (June 2019–September 2020); and late-implementation (October 2020–September 2021). Multivariable linear regression models were fit separately in each cohort.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>There were 449 and 2844 individuals in the intervention and control cohorts, respectively. Twelve months after transfer, participants in the late-implementation intervention cohort had an HbA1c that was, on average, 0.41% lower than participants in the pre-implementation period (<i>p</i> = 0.016). Among the control cohort, there was no significant difference in the HbA1c 12 months after transfer between study periods.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>We found an effect of the intervention on glycaemic management one year following transfer to adult care. Future work will focus on refining and testing the effectiveness of the intervention in an expanded number of study sites and in collaboration with adult diabetes care providers.</p>\n </section>\n </div>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":"42 1","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635587/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dme.15444","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

To test whether an audit and feedback-based intervention improved HbA1c 12 months after transfer to type 1 diabetes adult care.

Methods

Multi-centre, quasi-experimental pre-post study of an AF-based intervention targeting paediatric diabetes teams, which encouraged the implementation of an evidence-informed structured transition process at five paediatric diabetes centres in Ontario, Canada. Participants entered the study at their final paediatric visit. A parallel control cohort was ascertained using population-based administrative datasets. The primary outcome was HbA1c 12 months after transfer. The main exposure was the study period: pre-implementation (June 2018–May 2019); early-implementation (June 2019–September 2020); and late-implementation (October 2020–September 2021). Multivariable linear regression models were fit separately in each cohort.

Results

There were 449 and 2844 individuals in the intervention and control cohorts, respectively. Twelve months after transfer, participants in the late-implementation intervention cohort had an HbA1c that was, on average, 0.41% lower than participants in the pre-implementation period (p = 0.016). Among the control cohort, there was no significant difference in the HbA1c 12 months after transfer between study periods.

Conclusions

We found an effect of the intervention on glycaemic management one year following transfer to adult care. Future work will focus on refining and testing the effectiveness of the intervention in an expanded number of study sites and in collaboration with adult diabetes care providers.

Abstract Image

一项以审计和反馈为基础的干预措施,旨在改善转入成人 1 型糖尿病护理后一年内的糖尿病管理:多中心准实验研究。
目的:检验基于审计和反馈的干预措施是否能改善转入 1 型糖尿病成人护理 12 个月后的 HbA1c:在加拿大安大略省的五个儿科糖尿病中心,针对儿科糖尿病团队开展了一项基于 AF 的干预措施的多中心、准实验性前后期研究,该干预措施鼓励实施循证结构化过渡流程。参与者在儿科最后一次就诊时加入研究。利用基于人口的行政数据集确定了一个平行对照队列。主要结果是转院 12 个月后的 HbA1c。主要暴露是研究期间:实施前(2018 年 6 月至 2019 年 5 月);实施初期(2019 年 6 月至 2020 年 9 月);实施后期(2020 年 10 月至 2021 年 9 月)。对每个队列分别拟合了多变量线性回归模型:干预组和对照组分别有 449 人和 2844 人。转入干预队列 12 个月后,后期干预队列参与者的 HbA1c 平均比实施前低 0.41%(p = 0.016)。在对照组中,不同研究时期的参与者在转入干预组 12 个月后的 HbA1c 没有明显差异:结论:我们发现干预措施对转入成人护理一年后的血糖管理有影响。今后的工作重点是在更多的研究地点与成人糖尿病护理提供者合作,完善和测试干预措施的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetic Medicine
Diabetic Medicine 医学-内分泌学与代谢
CiteScore
7.20
自引率
5.70%
发文量
229
审稿时长
3-6 weeks
期刊介绍: Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions. The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信